跳至主要内容
临床试验/NCT01030276
NCT01030276Unknown不适用

Placebo-controlled, Double Blind RCT on the Efficacy of Bright Light Therapy in SAD

University of Oulu2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
2
主要终点
Remission as defined by the SIGH-SAD

研究概览

简要总结

The aim of this study is to investigate the efficacy of bright light therapy in SAD. This is a placebo-controlled, double-blind randomized controlled trial (RCT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • a patient has, according to the DSM-IV-TR, a Major depression, recurrent episode, seasonal pattern, "moderate" or "severe" (classification code 296.32 and 296.33)
  • HAMD-21 (included in the SIGH-SAD) sum score is ≥ 22
  • patient is over 18 years
  • patient can read and understand the subject information sheet
  • patient has signed the informed consent form
  • patient is not pregnant

排除标准

  • patient has a lifetime psychotic disorder
  • patient has a DSM-IV Axis I disorder other than some anxiety disorder evaluated by MINI
  • patient has some DSM-IV-TR Axis II disorder, which is likely to interfere with the study treatment according to the investigator
  • patient has alcohol or some other substance use dependence or misuse
  • life-time suicide attempt, or any thought of suicide during the last month
  • patients has some unstable somatic disorder
  • patient uses some medication on regular basis
  • patient uses some herbal psychotropic agencies
  • patient is, in the opinion of the investigator, unsuitable for any reason
  • patient is a member of the site personnel or their immediate families
  • patient has had bright light therapy during the current episode
  • patient has some eye disease (patient can, however, be myopic or hyperopic)

结局指标

主要结局

Remission as defined by the SIGH-SAD

时间窗: 28 (visit window from 26 to 30 days) days after the inclusion day

次要结局

  • Decrease of the severity of symptoms as assessed by SIGH-SAD, Hamilton anxiety scale, and Beck depression inventory-21(28 (visit window from 26 to 30 days) days)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验